Tanruprubart is a first-in-kind monoclonal antibody designed to block C1q, the initiating molecule of the classical complement cascade, with a single infusion to halt ongoing neuroinflammation and ...

Data is in for the first calendar quarter 2025 HDD industry from the May 2025 Digital Storage Technology Newsletter. Total HDD shipments in C1Q 2025 were down about 9.5% compared with C4Q 2024 (28 ...

Have you ever found yourself staring at a blank PowerPoint slide, unsure of where to start or how to make your presentation stand out? We’ve all been there—tight deadlines, creative blocks ...

D.C. consultant Seamus O’Neill stood before an attentive audience and cleared his throat. “Some of you may be wondering how rats got to D.C.,” he began. “Like most residents, rats came to ...

New research led by Nicole Scott-Hewitt, published in Cell, shows that neurons can also internalize C1q. C1q seems to influence protein production inside neurons by interacting with ribosomal ...

ANX005 is an intravenously (IV) administered C1q blocking antibody that inhibits the activation of the classical complement pathway. C1q is the initiating molecule of the classical complement ...

Also, new preclinical data on the role of C1q in the pathogenic elimination of photoreceptor synapses and protection of photoreceptors and their function with C1q blockade in GA will be presented ...

All were participants in the Genetic Frontotemporal Dementia Initiative (GENFI) cohort. Does C1q bind neuronal pentraxins also? These long pentraxins share homology with PTX3. Indeed, Zhou, and ...

Microsoft Powerpoint is undoubtedly one of the best presentation maker applications for Windows. However, like any other app, it also has its own errors and issues that keep troubling users.

How to integrate Power BI reports with a presentation in Microsoft PowerPoint Your email has been sent If your organization is using Microsoft Power BI mobile, you have access to a lot of data via ...

A new paradigm for tackling this dichotomy is to try to treat these diseases by blocking complement protein C1q, which tags synapses for elimination by glia. A C1q antibody hit its target in a Phase 2 ...